Invitation for Lantheus Holdings, Inc. Investors
Attention all investors of Lantheus Holdings, Inc. (NASDAQ: LNTH) who have experienced substantial losses. You now have an opportunity to take action in your favor by potentially leading a class action lawsuit.
About the Lawsuit
Robbins Geller Rudman & Dowd LLP is currently advocating for those who purchased Lantheus Holdings, Inc. securities from February 26, 2025, until August 5, 2025. For those who acquired shares during this designated period, the deadline to seek a lead plaintiff role is November 10, 2025.
What is the Class Action Lawsuit?
The case, Margolis v. Lantheus Holdings, Inc., highlights significant allegations against the company and several of its top executives regarding violations of the Securities Exchange Act of 1934. Claimants assert that Lantheus misrepresented crucial information concerning its growth prospects and financial outlook, which may have contributed to investor losses.
Nature of the Allegations
Lantheus specializes in developing and commercializing diagnostic products, particularly focusing on industries related to heart and cancer care. Notably, the company’s flagship product, Pylarify, is a PET imaging agent that plays a vital role in diagnosing and treating prostate cancer.
The lawsuit alleges that Lantheus’s leadership created a false narrative about the company’s expected revenue, dismissing risks associated with competition and economic fluctuations. These misleading reports painted an overly optimistic picture of sales growth and market stability, which ultimately did not reflect the actual situation.
Concerns intensified when Lantheus reported its first quarter results on May 7, 2025, revealing a year-over-year decline in Pylarify sales due to alleged market disruption. Following this, the company reduced its growth forecasts for the year, which led to a drastic drop in stock prices, reflecting the disconnect between reported expectations and actual performance.
Lead Plaintiff Eligibility
The Private Securities Litigation Reform Act lets any individual who acquired Lantheus securities during the specified class period seek lead plaintiff status in the lawsuit. Typically, this position is held by the individual with the most significant financial interest in the litigation outcome, and this role entails acting on behalf of all others in the class.
Benefits of Leading the Class Action
Taking on the role of lead plaintiff allows an investor to direct the class action's proceedings and select legal representation of their choosing. It's important to note that serving as the lead plaintiff does not affect the ability to participate in the recovery if a settlement or victory occurs.
About Robbins Geller Rudman & Dowd LLP
Robbins Geller Rudman & Dowd LLP stands as a preeminent law firm dedicated to representing investors in litigation related to securities fraud. Consistently ranked highly for representing class action cases, the firm recovered over $2.5 billion for investors in just the past year and continues to advocate fiercely for shareholder rights.
With a robust team of 200 lawyers across 10 offices, Robbins Geller is recognized as a powerful player in class action lawsuits. The firm possesses a proven track record in securing monumental recoveries for their clients, including significant landmark cases.
Contact Information
If you believe you are eligible and wish to learn more about joining the lead plaintiff process, it's essential to consult with knowledgeable attorneys. You may reach out directly to J.C. Sanchez or Jennifer N. Caringal at Robbins Geller by calling 800/449-4900.
Frequently Asked Questions
What is the deadline to join the Lantheus class action lawsuit?
The deadline for potential lead plaintiffs is November 10, 2025.
Who can participate in this lawsuit?
Investors who purchased or acquired Lantheus Holdings securities during the class period are eligible.
What damages are being sought in this lawsuit?
Investors are seeking compensation for losses incurred due to alleged misinformation regarding the company’s financial health and future performance.
What is the function of a lead plaintiff?
A lead plaintiff represents the interests of the class in the lawsuit, having the authority to guide proceedings and hold legal representation accountable.
Can I still recover damages if I’m not a lead plaintiff?
Yes, all investors who are part of the class can share in any financial recovery, regardless of whether they serve as lead plaintiff.
